- Report
- October 2026
- 366 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 190 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 189 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 283 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 153 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 276 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 108 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 254 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 138 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 278 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 376 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 280 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 266 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 497 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 257 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 384 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 227 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 290 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 276 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more